Valeant Pharma (NYSE: VRX) announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE